In October, 2007, the FDA issued a statement regarding Medtronic's
voluntary recall of their Sprint Fidelis Defibrillator Leads. This statement, issued by Daniel Shultz, M.D., Director of the Center for Devices and Radiological Health, said "Medtronic's decision to voluntarily remove its Sprint Fidelis defibrillation leads from the market is in the best interest of patient safety."U.S. Probes Off-Road Vehicles After a String of Accidents
11/04/08 - (read
more...)
Sherman Bus Crash
08/09/08 - (read
more...)
2008 Tire Recalls
05/02/08 - (read
more...)
Evenflo Recall of Discovery
Infant Child
Restraints
02/04/08 - (read
more...)
Medtronic Defibrillator Recall
12/03/07 - (read
more...)
Trasylol Pulled from U.S. Market
11/05/07 - (read
more...)
Tire Recalls
11/01/07 - (read
more...)
Safety vs. Savings on Consumer Products
10/30/07 - (read
more...)
Medtronic Defibrillator Recalled
10/30/07 - (read
more...)
FDA Update On Trasylol
10/26/07 - (read
more...)
Proposed Black Box Warning for Avandia
10/26/07 - (read
more...)
Medtronic and FDA Face Scrutiny on Safety Issues
10/17/07 - (read
more...)
Doctor Links a Man’s Illness to a Microwave
Popcorn Habit
9/05/07 - (read
more...)
Shorting Problem with Guidant ICD Device Causes Stir in EP Community
5/27/07 - (read
more...)